Cefdinir

Cefdinir is an oral third-generation cephalosporin commonly used to treat acute otitis media, particularly in children. It is effective against common pathogens like Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis, including some beta-lactamase–producing strains.

It’s a suitable alternative for children with non-severe penicillin allergies. Side effects may include diarrhea or red-colored stools, especially when taken with iron. While effective, cefdinir is typically considered a second-line option, with high-dose amoxicillin or amoxicillin-clavulanate preferred as first-line treatment.

Treatment Type: Prescription Medication

Treatment Class: Cephalosporin

Treatment Modality: Oral

Cefdinir

Review Summary

4.0

1 Reviews

Preferred by 1 Reviewers

Based on the provided review, Cefdinir is considered an effective treatment for acute otitis media (AOM), particularly against beta-lactamase-producing bacteria. The American Academy of Pediatrics recommends it as an alternative initial antibiotic, although it may be less effective than amoxicillin/clavulanate for treating penicillin-resistant Streptococcus pneumoniae.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
5.0
1 = Very Expensive 5 = Very Affordable

5.0

Very Affordable
Relief Speed
3.0
1 = No Relief 5 = Immediate Relief

3.0

Moderate Relief
Side Effects
5.0
1 = Intolerable Effect 5 = No Effect

5.0

No Effect
Treatment Line
3.0
1 = Third-line or more 5 = First-line

3.0

Second Line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

4.0

1 Reviews
5
0%
4
100%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the provided review, Cefdinir is considered an effective treatment for acute otitis media (AOM), particularly against beta-lactamase-producing bacteria. The American Academy of Pediatrics recommends it as an alternative initial antibiotic, although it may be less effective than amoxicillin/clavulanate for treating penicillin-resistant Streptococcus pneumoniae.

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
1 month ago
Cefdinir is an effective treatment for acute otitis media, especially against beta-lactamase-producing bacteria. It is recommended by the American Academy of Pediatrics as an alternative initial antibiotic. However, it may be less effective than amoxicillin/clavulanate for treating penicillin-resistant Streptococcus pneumoniae.
#VeryAffordable #CoveredByInsurance #ModerateRelief #NoEffect #Second-line #Rescue/EmergencyUse
View Professional Disclosures

Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All